|
WO2021043196A1
|
|
Use of 5-methyltetrahydrofolate
|
|
WO2021023263A1
|
|
Pharmaceutical composition producing safe amount of nitric oxide in body and use thereof
|
|
WO2021023118A1
|
|
Use of 5-methyltetrahydrofolic acid and composition of 5-methyltetrahydrofolic acid
|
|
CN108033962A
|
|
The method of one kind synthesis (6S) -5-methyltetrahydrofolate salt
|
|
WO2016034145A1
|
|
Composition of (6s)-5-methyl tetrahydrofolic acid or salt thereof as well as preparation therefor and application thereof
|
|
CN107812195A
|
|
The stabilizing pharmaceutical composition of (6S) 5 methyl tetrahydrofolate calcium salt
|
|
US2015065708A1
|
|
Compound JK12A and preparation thereof
|
|
US2015018357A1
|
|
Crystal form of (6S)-5-methyltetrahydrofolate salt and method for preparing same
|
|
CN102702200A
|
|
(6RS)-5-methyl tetrahydrofolate calcium salt crystal form and preparation process thereof
|
